Modalis Therapeutics

Modalis Therapeutics is a Japanese bio-venture that develops a unique genome editing technology "CRISPR-GNDM" that does not cut genes, which is more efficient and safer than conventional gene editing technology. By using "CRISPR-GNDM", Modalis Therapeutics develops therapeutic agents for gene-derived intractable diseases for which there is no therapeutic agent yet.


Contact us

© Copyright 2021 by Pegasus Tech Ventures


  • Серый Facebook Icon
  • Серый Twitter Иконка
  • Серый LinkedIn Иконка
  • Серый Instagram Иконка
  • Серый Значок YouTube